Stemline Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 25 U.S.-traded ETFs. STML has around 3.4M shares in the U.S. ETF market. The largest ETF holder of STML is the SPDR S&P Biotech ETF (XBI), with approximately 1.15M shares. Investors may also find of interest that the ETF with the largest allocation to STML stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 1.69%. On average, U.S. ETFs allocate 0.11% of STML to their portfolios.
Additionally, STML is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with STML as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.